Triochem Products Ltd — Others, 02-06-2025: AGM/EGM

Triochem Products Limited has announced a board meeting to consider the financial results for the quarter and half-year ended March 31, 2025. The 53rd Annual General Meeting will be held at the registered office to approve key items including adoption of audited financials, re-appointment of directors Mr. Rajesh Ranu Deora and Mr. Ranu Sitaram Deora who retire by rotation, appointment of M/s. Ragini Chokshi & Co. as secretarial auditors for five years, continuation of Mr. Ranu Sitaram Deora's directorship despite being over 75 years, appointment of Mr. Shailendra Omprakash Mishra and Mr. Vipul Amul Desai as independent directors for five years, and authorisation of related party transactions. The company reported a loss of Rs. 40.01 lakh for FY25, narrowing from Rs.101.33 lakh loss in FY24, with revenue from operations temporarily nil due to reduced post-pandemic activity. The company is maintaining liquidity, focusing on cost control and supply chain monitoring, with an expectation of market stabilization in FY26. Directors receive no remuneration; the company has no subsidiaries and operates in the single segment of bulk drugs. The equity share capital stands at Rs.24.5 lakh with no changes during the year. Key audit and secretarial audit reports were unqualified. The company continues to prioritize internal control effectiveness, human resource development, workplace safety, and legal compliance, while dealing with income tax disputes and an exceptional item related to IGST interest of Rs.115.65 lakh from prior years.